您好,欢迎您来到格朗瑞生物科技公司网站!
[登录]
[注册]
  • Content

Axolbio/axolGEM iPSC-Derived Neural Stem Cells MAPT R406W HOM/ax0320/1 Ea

细胞培养
Axolbio/axolGEM iPSC-Derived Neural Stem Cells MAPT R406W HOM/ax0320/1 Ea


商品编号


ax0320



品牌


Axolbio



公司


Axolbio



公司分类


Human Cells




1 Ea

商品信息
axolGEM iPSC-Derived Neural Stem Cells MAPT R406W HOM (1.5 million cells) and Neural Plating-XF Medium (30 mL)
Description:
Human iPSC-Derived Neural Stem Cells that have been genetically edited using CRISPR-Cas9 technology to introduce the R406W mutation (CGG>TGG) into the
MAPT
gene. This line is homozygous for the R406W mutation so both alleles contain the mutation. Click on the product images to see the data and further details.?

The R406W mutation in MAPT has been implicated in familial frontotemporal dementia and parkinsonism?(Hutton?
et al
., 1998; Behnam
et al
., 2015) and has been seen in patients with clinical presentation resembling Alzheimer's disease (Rademakers
et al
., 2003;?Lindquist
et al
., 2008). The R406W mutation reduces the
ABI
lity of MAPT/tau to bind to microtubules
in vitro
(Hong
et al
., 1998).?

Click here to see more data on Axol Neural Stem Cells
Product Specification:


Starting material

Dermal fibroblast



Donor gender

Female



Donor age at sampling

64 yrs



Karyotype

Normal



Reprogramming method

Episomal vector



Induction method

Monolayer & chemically defined medium



Genetic modification

Homozygous for the MAPT R406W mutation (CGG>TGG)



Genetic modification

Contains a puromycin resistance cassette (intronic)



Size

≥1.5 million cells



Kit components

1 vial of axolGEM Neural Stem Cells (≥1.5 million cells) and 1 bottle of Plating-XF Medium (30 mL)



Growth properties

Adherent



Shipping conditions

Dry ice



Storage conditions

Liquid nitrogen


上一篇 Axolbio/axolGEM iPSC-Derived Neural Stem Cells MAPT R406W HET/ax0321/1 Ea  下一篇 Axolbio/axolGEM iPSC-Derived Neural Stem Cells LRRK2 G2019S HET/ax0311/1 Ea

产品货号:14236.0

14236.0 ¥
11至15个工作日送达